Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 235-240

  De Weers, M ^a   Dingjan, G M ^b   Brouns, G S ^c   Kraakman, M E M ^a   Mensink, R G J ^a   Lovering, R C ^d   Schuurman, R K B ^a   Borst, J ^c   Hendriks, R W ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

B lymphoblastoid cell lines; Bruton's tyrosine kinase; X linked agammaglobulinaemia; X linked immunodeficiency

Indexed keywords

PROTEIN TYROSINE KINASE;

AGAMMAGLOBULINEMIA; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; LYMPHOBLASTOID CELL LINE; MALE; MUTATION; PHENOTYPE; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

EID: 0031028268     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.296-ce1185.x     Document Type: Article

References (26)

1. Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 1995; 59:135-223.
2. Conley ME, Parolini O, Rohrer J, Campana D, X-linked agamma-globulinenia: new approaches to old questions based on the identification of the defective gene. Immunol Rev 1994; 138:5-21.
3. Smith CIE, Islam KB, Vorechovsky I, Olerup O, Wallin E, Rabbani H, Baskin B, Hammarström L. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev 1994; 138:159-83.
4. Rawlings DJ, Witte ON. Bruton's tyrosine kinase is a key regulator in B cell development. Immunol Rev 1994; 138:105-19.
5. Vihinen M, Iwata T, Kinnon C, Kwan SP, Ochs HD, Vorechovsky I, Smith CIE. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucl Acids Res 1996; 24:160-5.
6. Bykowsky M, Haire RN, Ohta Y et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 1996; 58:477-83.
7. Genevier HC, Hinshelwood S, Caspar HB et al. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol 1994; 24:3100-5.
8. Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72:279-90.
9. Saffran DC, Parolini OP, Fitch-Hilgenberg ME, Rawlings DJ, Afar DEH, Witte ON, Conley ME. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 1994; 330:1488-91.
10. De Weers M, Mensink RGJ, Kraakman MEM, Schuurman RKB, Hendriks RW. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeticient xid mice. Hum Mol Genet 1994; 3:161-6.
11. Mensink EJBM, Thompson A, Schot JDL, van de Greef WMM. Sandkuyl LA, Schuurman RKB. Mapping of a gene for X-linked agammaglobulinemia and evidence for heterogeneity. Hum Genet 1986; 73:327-32.
12. Bradley LAD. PhD thesis, University of London. 1995.
13. Grosveld FG, Lund T, Murray EJ, Mellor AL, Dahl HHM, Flavell RA. The construction of cosmid libraries which can be used to transform eukaryotic cells. Nucleic Acids Res 1982; 10:6715-32.
14. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
15. De Weers M, Verschuren MCM, Kraakman MEM, Mensink RGJ, Schuurman RKB, Van Dongen JJM, Hendriks RW. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol 1993; 23:3109-14.
16. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein tyrosine kinases. Nature 1993; 361:226-33.
17. De Weers M, Brouns GS, Hinshelwood S, Kinnon C, Schuurman RKB, Hendriks RW, Borst J. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem 1994; 269:23857-60.
18. Mensink EJBM, Schot JDL, Tippett O, Ott J, Schuurman RKB. X-linked agammaglobulinemia and the red blood determinants Xg and 12E7 are not closely linked. Hum Genet 1984; 68:303-9.
19. Cooper DN, Krawczak M. Mechanisms of insertionl mutagenesis in human genes causing genetic disease. Hum Genet 1991; 87:409-15.
20. Losson R, Lacroute F. Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 1979; 76:5134-7.
21. Urlaub G, Mitchell PJ, Ciudad CJ, Chasin LA. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 1989; 9:2868-80.
22. Peltz SW, Brown AH, Jacobson A. mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor. Genes Dev 1993; 7:1737-54.
23. Himmelman A, Thevenin C, Harrison K, Kehrl JH. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and Sp1 sites. Blood 1996; 87:1036-44.
24. Oeltjen JC, Liu X, Lu J, Allen RC, Muzny D, Belmont JW, Gibbs RA. Sixty-nine kilobases of contiguous human genomic sequence containing the α-galactosidase A and Button's tyrosine kinase loci. Mammal Genome 1995; 6:334-8.
25. Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 1994; 3:1751-6.
26. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T. Btk as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 1996; 273:1096-100.